Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Eur Urol.

Dahm P, Brasure M, MacDonald R, Olson CM, Nelson VA, Fink HA, Rwabasonga B, Risk MC, Wilt TJ

doi: 10.1016/j.eururo.2016.09.032.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis

Eur Radiol.

Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L

doi: 10.1007/s00330-018-5564-2.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

Eur Urol Focus.

Zumstein V, Betschart P, Vetterlein MW, Kluth LA, Hechelhammer L, Mordasini L, Engeler DS, Kessler TM, Schmid HP, Abt D

doi: 10.1016/j.euf.2018.09.005.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

The UK ROPE Study: efficacy and safety of prostate artery embolisation for benign prostatic hyperplasia. An observational study and propensity matched comparison with transurethral resection of the prostate

BJU Int.

Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, Modi S, Dyer J, Harris M, Carolan-Rees G, Hacking N

doi: 10.1111/bju.14249.

Uro-Oncology

Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS)

J Urol.

Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW

doi: 10.1016/j.juro.2018.07.065.

Benign Prostatic Hyperplasia (BPH)

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels

Int J Environ Res Public Health.

Rył A, Rotter I, Grzywacz A, Małecka I, Skonieczna-Żydecka K, Grzesiak K, Słojewski M, Szylińska A, Sipak-Szmigiel O, Piasecka M, Walczakiewicz K, Laszczyńska M

doi: 10.3390/ijerph14111318.

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms

Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review

Aging Male.

MacDonald R, Brasure M, Dahm P, Olson CM, Nelson VA, Fink HA, Risk MC, Rwabasonga B, Wilt TJ

doi: 10.1080/13685538.

Benign Prostatic Hyperplasia (BPH)

Critical Analysis of a Multicentric Experience with Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia: Outcomes and Complications of Ten Years of Routine Clinical Practice

BJU Int.

Romero-Otero J, García-Gómez B, García-González L, García-Rojo E, Abad-López P, Justo-Quintas J, Duarte Ojeda J, Rodríguez Antolín A

doi: 10.1111/bju.15028.

Benign Prostatic Hyperplasia (BPH)

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies

Medicine (Baltimore).

Xu H, Fu S, Chen Y, Chen Q, Gu M, Wang Z.

doi: 10.1097/

Related content

Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.

Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis

Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis

The UK ROPE Study: efficacy and safety of prostate artery embolisation for benign prostatic hyperplasia. An observational study and propensity matched comparison with transurethral resection of the prostate

Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS)

Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels

Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review

Critical Analysis of a Multicentric Experience with Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia: Outcomes and Complications of Ten Years of Routine Clinical Practice

Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies